Overview

Effects of GLP-1 on Chronic Heart Failure

Status:
Unknown status
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The investigators planned to evaluate the effects of liraglutide on left ventricular function in chronic heart failure patients with type 2 diabetes.
Phase:
N/A
Details
Lead Sponsor:
Shi Yang
Treatments:
Glucagon-Like Peptide 1
Liraglutide